Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.54
0.096.21%
Last update: Oct 9, 7:14 PM
$1.55
0.106.9%
Palisade Bio Inc (PALI) Stock Price, Quote, News & History
PALINASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Palisade Bio (NASDAQ:PALI) through any online brokerage.
Other companies in Palisade Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Palisade Bio has a consensus price target of $10.10.
The stock price for Palisade Bio (NASDAQ: PALI) is $1.55 last updated October 9, 2026 at 7:14 PM EDT.
There are no upcoming dividends for Palisade Bio.
Palisade Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Palisade Bio.
Palisade Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
